Drug-induced lupus erythematosus epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Overview
Prevalence
Prevalence
Case-Fatality Rate
Case-Fatality Rate
- There is no information about case-fatality rate on drug-induced lupus, but it can be potentially fatal. 16466117 [2]
Age
Age
Patients with DILE tend to be older (50–70 years old) than those with SLE (average age 29 years at diagnosis). Elderly persons generally are more susceptible to DILE.
Gender
Gender
In DIL, no significant statistical difference is apparent in the prevalence for males versus females. In contrast, SLE affects women with considerably higher frequency than men (female-to-male ratio of 9:1).
Ethnicity
Ethnicity
More whites than blacks develop DIL; more blacks than whites present with SLE.
References
References
- ↑ “StatPearls”. 2021. PMID 28722919.
- ↑ Finks SW, Finks AL, Self TH (2006). “Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure”. South Med J. 99 (1): 18–22. doi:10.1097/01.smj.0000197121.12352.19. PMID 16466117.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
